Oppenheimer Boosts 2U (TWOU) Price Target to $83.00

2U (NASDAQ:TWOU) had its price objective upped by equities researchers at Oppenheimer from $70.00 to $83.00 in a note issued to investors on …

2U logo2U (NASDAQ:TWOU) had its price objective upped by equities researchers at Oppenheimer from $70.00 to $83.00 in a note issued to investors on Tuesday, February 26th, The Fly reports. The firm presently has an “outperform” rating on the software maker’s stock. Oppenheimer’s target price would suggest a potential upside of 20.17% from the stock’s previous close. Oppenheimer also issued estimates for 2U’s Q1 2019 earnings at ($0.35) EPS, Q2 2019 earnings at ($0.55) EPS, Q3 2019 earnings at ($0.27) EPS, Q4 2019 earnings at $0.03 EPS and FY2019 earnings at ($1.13) EPS.

TWOU has been the subject of several other reports. DA Davidson set a $80.00 price target on 2U and gave the stock a “buy” rating in a research note on Tuesday, November 6th. BMO Capital Markets dropped their price target on 2U from $93.00 to $75.00 and set a “positive” rating for the company in a research note on Tuesday, November 6th. Credit Suisse Group dropped their price target on 2U from $100.00 to $80.00 and set an “outperform” rating for the company in a research note on Tuesday, November 6th. First Analysis set a $95.00 price target on 2U and gave the stock a “buy” rating in a research note on Friday, November 16th. Finally, KeyCorp upped their price target on 2U from $65.00 to $80.00 and gave the stock an “in-line” rating in a research note on Tuesday, February 26th. Six analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. 2U currently has an average rating of “Buy” and an average target price of $87.42.

Shares of NASDAQ:TWOU opened at $69.07 on Tuesday. The stock has a market cap of $4.02 billion, a price-to-earnings ratio of -109.63 and a beta of 0.75. The company has a quick ratio of 7.62, a current ratio of 7.62 and a debt-to-equity ratio of 0.03. 2U has a 12 month low of $44.50 and a 12 month high of $98.58.

2U (NASDAQ:TWOU) last announced its quarterly earnings results on Monday, February 25th. The software maker reported $0.23 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.21 by $0.02. The company had revenue of $115.10 million during the quarter, compared to analyst estimates of $114.90 million. 2U had a negative return on equity of 5.77% and a negative net margin of 9.31%. The firm’s revenue was up 32.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.14 earnings per share. Research analysts predict that 2U will post -1.14 EPS for the current fiscal year.

Hedge funds have recently bought and sold shares of the company. Tompkins Financial Corp acquired a new stake in shares of 2U in the fourth quarter valued at about $26,000. Rehmann Capital Advisory Group acquired a new stake in shares of 2U in the fourth quarter valued at about $34,000. Captrust Financial Advisors grew its stake in shares of 2U by 352.8% in the fourth quarter. Captrust Financial Advisors now owns 1,046 shares of the software maker’s stock valued at $52,000 after buying an additional 815 shares in the last quarter. Mycio Wealth Partners LLC acquired a new stake in shares of 2U in the fourth quarter valued at about $74,000. Finally, Parkside Financial Bank & Trust grew its stake in shares of 2U by 94.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,576 shares of the software maker’s stock valued at $78,000 after buying an additional 764 shares in the last quarter.

2U Company Profile

2U, Inc operates as an education technology company in the United States, Hong Kong, South Africa, and the United Kingdom. The company operates through two segments, Graduate Program Segment and Short Course Segment. It offers front-end technology and services, including online learning platform, student and faculty and immersion support, accessibility, admissions application advising, in-program student field placements, and faculty recruiting.

See Also: Why do corrections happen?

The Fly

Analyst Recommendations for 2U (NASDAQ:TWOU)

Receive News & Ratings for 2U Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for 2U and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Trading Review: Investors Keen on Finisar Corporation (NASDAQ:FNSR) as it Makes Headlines …

Major market players are buzzing over Finisar Corporation (NASDAQ:FNSR) as their share price hit $23.73 at the end of the most recent trading …

Major market players are buzzing over Finisar Corporation (NASDAQ:FNSR) as their share price hit $23.73 at the end of the most recent trading session.

Market capitalization is the total dollar market value of a company’s shares. It is calculated by multiplying a company’s shares outstanding by the current market price of one share. Investors use this figure to figure out a company’s size, as opposed to just using total asset or sales figures. Market capitalization is important because company size is a basic indicator of multiple characteristics in which investors are interested in, including risk. It is easy to calculate. For example, a company with 40 million shares selling at $100 a share would have a market cap of $4 billion. Companies are ranked according to their market caps, ranking them as large-cap, mid-cap and small-cap. Large-cap companies usually have a market capitalization of $10 billion and up. These large-cap companies have typically been around for a long period of time, and they are usually major players in well-established industries. Mid-cap companies have a market capitalization of $2 billion – $10 billion. Mid-cap companies operate in industries expected to experience rapid growth. Companies that have a market capitalization $300 million – $2 billion are classified as small-cap companies. These companies are usually young in age and they could serve new industries as well as niche markets. Finisar Corporation (NASDAQ:FNSR)’s market cap is $2797.85.

Average Volume is the amount of securities traded in a day on average over a specific time period. Trading activity relates to the liquidity of a security. When average volume is high, the stock has high liquidity and can be therefore easily traded, while conversely, when the trading volume is low, the commodity will be less expensive as traders are not as willing to purchase it. Average volume has an effect on the price of the security. Finisar Corporation (NASDAQ:FNSR) has experienced an average volume of 1283774.

The mathematical calculation that represents the degree of change over time is known as “percentage change”. In finance, it serves many purposes, and is often used to represent the price change of a commodity.

Finisar Corporation (NASDAQ:FNSR)’s Price Change % over the last week is -1.37%. It’s % Price Change over the previous month is 3.4% and previous three months is 10.06%. Finally, looking back over the past year-to-date, Finisar Corporation (NASDAQ:FNSR)’s Price Change % is 9.86%.

Outstanding shares are common stock authorized by a company that are issued, purchased, and held by investors. Outstanding shares include restricted shares owned by the company’s employees and officers as well as the public. “Capital Stock” is the number of outstanding shares listed on a company’s balance sheet and is reported with the company’s quarterly filings with the US Securities and Exchange Commission. Finisar Corporation (NASDAQ:FNSR)’s shares outstanding are 117.9.

Any given stock may have anywhere between 1 to 40 brokerage analysts making EPS estimates as they follow the company. Zacks have been tracking these sell-side analyst estimates for more than 25 years, creating consensus EPS estimates. These estimates are the average of all of the current estimates that are made available by brokerage analysts. Consensus estimates are better because they reduce the risk of any single analyst making an incorrect forecast. In the case of Finisar Corporation (NASDAQ:FNSR), Zacks tracked 8 brokers to create the consensus EPS estimate.

Zacks calculates consensus estimates for the current quarter, the following quarter, the current fiscal year, the following fiscal year, and also a long-term growth rate. A company can “Meet” the same earnings as forecast, “Beat” the earnings than forecast, or “Miss” (fall below) the earnings than forecast. Missing a forecast, of course, is the worst outcome, as it indicates that the company is not performing as well as investors thought. A “Miss” often causes the share price to fall.

Zacks tracked 5 analysts to create a quarterly consensus estimate of 0.28 for Finisar Corporation (NASDAQ:FNSR).

Zacks tracked [5 analysts to create a consensus of 0.27 for the last completed fiscal quarter for Finisar Corporation (NASDAQ:FNSR).

The investment research firm, Zacks Investment Research, Inc. uses a mathematical quantitative stock-rating system to capture the power of earnings estimates incorporating full text research reports, back-testing, proprietary models, reporting, and raw data. Zacks provide research coverage for companies by combining both traditional fundamental analysis and quantitative models. They provide price response indicators, equity research, market summary, estimate analytics, portfolio tracker, rank stocks, mutual funds reports, exchange traded funds reports, finance reports, options report, video commentaries, earnings analysis, and education reports.

The firm provides small-cap research with focus on small and micro-cap companies and well-positioned for future growth. Zacks provide institutional research for small cap portfolios. Within their stocks report, the firm provides bullish and bearish stock of the day, a stock picking strategies report, analyst blogs, weekly market analysis, daily research reports, stock ranks, including industry rank analysis, a mutual fund rank, top sector rank, a market outlook report, and exchange traded fund rank.

For their fund analysis, Zacks offers exchange traded fund and mutual funds reports including tools, headlines, funds commentaries, exchange traded funds, rank guides, fund screener, education resources report, and education ranks.

Within Zacks earning analysis, they offer earnings expected surprise prediction, screeners, news, earning updates, earning events, and calendar. Within screening analysis, the firm offers trading resources, screen tools, quant monitor, and premium screens.

Zacks offers financial analysis on investing, insurance, real estate, money managing, tax information, and retirement planning. They also offer desktop search utility, including web pages displaying recommendations, analyst track records from all brokerage firms, and current EPS and sales estimates. Their desktop search utility provides consulting services, historical updates and data on inactive and active Canadian and United States equities, total return industry index series, monthly economic outlook, bi-weekly model portfolio, monthly market strategy overview, quantitative reports, personalized research summary, income statement model, summarized company reports, and compliance services.

They partake in earnings conference calls, company sponsored events, and investment conferences. The firm caters to portfolio managers, professional investors, investment managers, publicly listed corporations, asset and hedge fund managers, research analysts, buy side investment professionals, and retail investors. Zacks Investment Research, Inc. is based in Chicago, Illinois and was founded in 1978.

Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information.

Related Posts:

  • No Related Posts

BidaskClub Downgrades Sterling Construction (STRL) to Hold

Millennium Management LLC increased its holdings in Sterling Construction by 18.9% in the 4th quarter. Millennium Management LLC now owns …

Sterling Construction logoSterling Construction (NASDAQ:STRL) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a report released on Thursday, March 7th.

A number of other research firms have also weighed in on STRL. ValuEngine raised shares of Sterling Construction from a “sell” rating to a “hold” rating in a research note on Wednesday, January 2nd. Zacks Investment Research lowered shares of Sterling Construction from a “hold” rating to a “sell” rating in a research report on Friday, November 9th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the company. Sterling Construction presently has a consensus rating of “Hold” and an average price target of $17.50.

STRL stock traded down $0.10 during mid-day trading on Thursday, reaching $13.37. 244,000 shares of the stock traded hands, compared to its average volume of 172,450. The company has a quick ratio of 1.67, a current ratio of 1.69 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $358.84 million, a price-to-earnings ratio of 14.38, a price-to-earnings-growth ratio of 1.08 and a beta of 1.07. Sterling Construction has a one year low of $9.71 and a one year high of $16.07.

Sterling Construction (NASDAQ:STRL) last posted its quarterly earnings results on Monday, March 4th. The construction company reported $0.21 EPS for the quarter, topping the Zacks’ consensus estimate of $0.19 by $0.02. Sterling Construction had a net margin of 2.43% and a return on equity of 15.44%. The firm had revenue of $255.18 million for the quarter, compared to analysts’ expectations of $247.85 million. As a group, equities research analysts expect that Sterling Construction will post 1.15 EPS for the current year.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Geode Capital Management LLC increased its holdings in Sterling Construction by 6.1% in the 4th quarter. Geode Capital Management LLC now owns 276,986 shares of the construction company’s stock worth $3,016,000 after buying an additional 15,917 shares during the period. Walthausen & Co. LLC increased its holdings in Sterling Construction by 39.2% in the 4th quarter. Walthausen & Co. LLC now owns 166,300 shares of the construction company’s stock worth $1,811,000 after buying an additional 46,870 shares during the period. Penn Capital Management Co. Inc. acquired a new position in Sterling Construction in the 4th quarter worth approximately $1,548,000. Millennium Management LLC increased its holdings in Sterling Construction by 18.9% in the 4th quarter. Millennium Management LLC now owns 316,225 shares of the construction company’s stock worth $3,444,000 after buying an additional 50,226 shares during the period. Finally, Macquarie Group Ltd. grew its stake in shares of Sterling Construction by 111.1% during the 4th quarter. Macquarie Group Ltd. now owns 3,800 shares of the construction company’s stock worth $41,000 after purchasing an additional 2,000 shares during the period. Hedge funds and other institutional investors own 78.14% of the company’s stock.

Sterling Construction Company Profile

Sterling Construction Company, Inc, together with its subsidiaries, operates as a heavy civil and residential construction company in Arizona, California, Colorado, Hawaii, Nevada, Texas, Utah, and other states in the United States. The company’s Heavy Civil Construction segment undertakes heavy civil construction projects, including highways, roads, bridges, airfields, ports, light rail, water, wastewater and storm drainage systems, foundations for multi-family homes, commercial concrete projects, and parking structures.

Featured Article: What is the Coverage Ratio?

Receive News & Ratings for Sterling Construction Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Sterling Construction and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Aurora Cannabis (ACB) Downgraded to D+ at TheStreet

TheStreet downgraded shares of Aurora Cannabis (NYSE:ACB) from a c rating to a d+ rating in a report published on Monday, February 25th. Several …

Aurora Cannabis Inc logoTheStreet downgraded shares of Aurora Cannabis (NYSE:ACB) from a c rating to a d+ rating in a report published on Monday, February 25th.

Several other analysts have also weighed in on ACB. GMP Securities reissued a hold rating and issued a $9.50 price objective on shares of Aurora Cannabis in a report on Tuesday, February 12th. Seaport Global Securities assumed coverage on Aurora Cannabis in a report on Thursday, February 21st. They set a neutral rating for the company. Finally, Jefferies Financial Group assumed coverage on Aurora Cannabis in a report on Monday, February 25th. They set a buy rating for the company. One research analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. The company has a consensus rating of Buy and a consensus price target of $9.50.

Shares of NYSE:ACB traded down $0.08 during trading on Monday, hitting $8.99. The company’s stock had a trading volume of 56,250,495 shares, compared to its average volume of 29,169,904. The company has a debt-to-equity ratio of 0.08, a quick ratio of 2.50 and a current ratio of 3.31. Aurora Cannabis has a fifty-two week low of $4.05 and a fifty-two week high of $12.52. The stock has a market cap of $8.06 billion, a price-to-earnings ratio of 74.92 and a beta of 2.90.

Aurora Cannabis (NYSE:ACB) last released its quarterly earnings results on Monday, February 11th. The company reported ($0.04) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.06) by $0.02. The business had revenue of $41.00 million for the quarter. Aurora Cannabis had a positive return on equity of 3.95% and a negative net margin of 57.54%. On average, equities research analysts predict that Aurora Cannabis will post -0.17 EPS for the current year.

Several large investors have recently bought and sold shares of the company. Financial Advocates Investment Management bought a new position in Aurora Cannabis in the 4th quarter worth approximately $74,000. Flagship Harbor Advisors LLC bought a new position in Aurora Cannabis in the 4th quarter worth approximately $26,000. Advisory Services Network LLC bought a new position in Aurora Cannabis in the 4th quarter worth approximately $29,000. Trustcore Financial Services LLC bought a new position in Aurora Cannabis in the 4th quarter worth approximately $33,000. Finally, Farmers & Merchants Trust Co of Chambersburg PA bought a new position in Aurora Cannabis in the 4th quarter worth approximately $36,000. 8.16% of the stock is owned by institutional investors.

About Aurora Cannabis

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Read More: What are the reasons investors use put options?

Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

WINTON GROUP Ltd Grows Holdings in EXACT Sciences Co. (NASDAQ:EXAS)

WINTON GROUP Ltd grew its stake in EXACT Sciences Co. (NASDAQ:EXAS) by 85.0% during the 4th quarter, according to the company in its most …

EXACT Sciences logoWINTON GROUP Ltd grew its stake in EXACT Sciences Co. (NASDAQ:EXAS) by 85.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,618 shares of the medical research company’s stock after purchasing an additional 5,338 shares during the period. WINTON GROUP Ltd’s holdings in EXACT Sciences were worth $733,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. CWM LLC grew its stake in shares of EXACT Sciences by 777.1% in the 4th quarter. CWM LLC now owns 614 shares of the medical research company’s stock valued at $39,000 after purchasing an additional 544 shares during the period. Strs Ohio bought a new stake in EXACT Sciences during the 4th quarter worth approximately $161,000. First Republic Investment Management Inc. bought a new stake in EXACT Sciences during the 3rd quarter worth approximately $204,000. Crossmark Global Holdings Inc. bought a new stake in EXACT Sciences during the 3rd quarter worth approximately $220,000. Finally, Mogy Joel R Investment Counsel Inc. bought a new stake in EXACT Sciences during the 3rd quarter worth approximately $221,000. Institutional investors own 91.08% of the company’s stock.

EXAS traded up $1.36 during mid-day trading on Thursday, reaching $96.15. The stock had a trading volume of 1,196,232 shares, compared to its average volume of 1,864,439. The firm has a market capitalization of $11.78 billion, a price-to-earnings ratio of -70.70 and a beta of 1.85. The company has a debt-to-equity ratio of 1.02, a quick ratio of 8.70 and a current ratio of 8.99. EXACT Sciences Co. has a 52 week low of $37.36 and a 52 week high of $97.27.

EXACT Sciences (NASDAQ:EXAS) last announced its quarterly earnings data on Thursday, February 21st. The medical research company reported ($0.44) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.49) by $0.05. The firm had revenue of $142.98 million for the quarter, compared to analyst estimates of $143.00 million. EXACT Sciences had a negative return on equity of 23.58% and a negative net margin of 38.54%. The business’s quarterly revenue was up 63.6% compared to the same quarter last year. During the same period last year, the company earned ($0.18) EPS. As a group, research analysts forecast that EXACT Sciences Co. will post -1.98 EPS for the current year.

A number of equities research analysts recently commented on EXAS shares. Zacks Investment Research upgraded EXACT Sciences from a “hold” rating to a “buy” rating and set a $84.00 price target on the stock in a research report on Thursday, January 17th. Canaccord Genuity increased their price target on EXACT Sciences from $87.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, January 14th. BidaskClub upgraded EXACT Sciences from a “hold” rating to a “buy” rating in a research report on Thursday, January 10th. UBS Group increased their price target on EXACT Sciences from $100.00 to $109.00 and gave the stock a “buy” rating in a research report on Monday, January 28th. Finally, Craig Hallum set a $95.00 price target on EXACT Sciences and gave the stock a “buy” rating in a research report on Friday, February 22nd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. EXACT Sciences currently has a consensus rating of “Buy” and an average price target of $99.64.

In other news, CFO Jeffrey Thomas Elliott sold 90,909 shares of the stock in a transaction on Thursday, January 24th. The stock was sold at an average price of $78.90, for a total value of $7,172,720.10. Following the transaction, the chief financial officer now owns 124,120 shares of the company’s stock, valued at approximately $9,793,068. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Kevin T. Conroy sold 9,169 shares of the stock in a transaction on Wednesday, February 27th. The shares were sold at an average price of $95.07, for a total value of $871,696.83. Following the completion of the transaction, the insider now directly owns 923,961 shares in the company, valued at approximately $87,840,972.27. The disclosure for this sale can be found here. Insiders sold a total of 445,896 shares of company stock worth $36,518,057 over the last quarter. Corporate insiders own 3.20% of the company’s stock.

TRADEMARK VIOLATION WARNING: “WINTON GROUP Ltd Grows Holdings in EXACT Sciences Co. (NASDAQ:EXAS)” was originally published by Fairfield Current and is the sole property of of Fairfield Current. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.fairfieldcurrent.com/news/2019/03/14/exact-sciences-co-exas-position-increased-by-winton-group-ltd.html.

About EXACT Sciences

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer.

Featured Story: Why are percentage gainers important?

Institutional Ownership by Quarter for EXACT Sciences (NASDAQ:EXAS)

Receive News & Ratings for EXACT Sciences Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for EXACT Sciences and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts